Major Scope

  •  Cardiovascular Case Reports
  •  Oncology Case Reports
  •  Surgical Case Reports
  •  Gastroenterological Case Reports
  •  Neurological Case Reports
  •  Dermatological Case Reports
  •  Respiratory Case Reports
  •  Obstetrics/Gynecology Case Reports
  •  Nephrology Case Reports
  •  Immunology Case Reports
  •  Paediatric Case Reports
  •  Orthopedics Case Reports
  •  Dental Case Reports

Abstract

Citation: Ann Clin Case Rep. 2024;9(1):2631.DOI: 10.25107/2474-1655.2631

The Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on a Child with X-Linked Intellectual Disability Caused by HUWE1 Gene Mutation: A Case Report

Yang S-T, Wang C-L* and Kong Y-M

Department of Pediatrics, The First Affiliated Hospital Zhejiang University School of Medicine, China

*Correspondance to: Wang C-L 

 PDF  Full Text Research Article | Open Access

Abstract:

Background: X-Linked Intellectual Disability (XLID) is caused by pathogenic variation of genes on X chromosome, accounting for approximately 15% of all intellectual disability cases. Case Report: A 6-year and 6-month-old girl had one seizure each at 9 and 10 months of age, and both the seizure episodes were generalized seizures, with or without fever. The girl's motor and language development are delayed. Her lower limbs are of unequal length. Meanwhile, her height is growing slowly and lower than the 3rd percentile of children of the same age and sex. There were no obvious abnormalities in her head Computed Tomography (CT) and Electroencephalogram (EEG). A de-novel heterozygous mutation of HUWE1 gene exon 82 (c.12702T>G, p.Ile4234Met) was identified by whole-exon sequencing (Trio-WES). There was no variation at this locus in her parents. The peak of her growth hormone is 10.6 ng/ml. She began receiving the recombinant human Growth Hormone(rhGH) therapy at the age of 4 years and 6 months and continued for two years, her height showed improvement. Conclusion: We reported a girl with XLID caused by HUWE1 gene mutation, she carried the novel heterozygous HUWE1 mutation, and there are only a few reports of X-linked intellectual disability caused by HUWE1 mutation worldwide. In clinical work, for children with intellectual disability and growth retardation, or with a clear family history of abnormalities, gene testing should be actively carried out to clarify the reason.

Keywords:

HUWE1 gene; Mutation, X-linked intellectual disability; Recombinant human growth hormone

Cite the Article:

Yang S-T, Wang C-L, Kong Y-M. The Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on a Child with X-Linked Intellectual Disability Caused by HUWE1 Gene Mutation: A Case Report. Ann Clin Case Rep. 2024; 9: 2631..

Journal Basic Info

  • Impact Factor: 5.253*
  • H-Index: 6
  • ISSN: 2474-1655
  • DOI: 10.25107/2474-1655
  • PubMed NLM ID: 101702800

Search Our Journal

Journal Indexed In

Articles in PubMed

Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II
 PubMed  PMC  PDF  Full Text
Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and other Naturally Occurring Compounds, Part I
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Extensive Right Coronary Artery Thrombosis in a Patient with Coronavirus Disease 2019
 Abstract  PDF  Full Text
FAM83D and Malignant Tumors: A Brief Literature Review
 Abstract  PDF  Full Text
View More...